NICE rejects Nexavar – again

NICE has again proposed the refusal of NHS funding for Nexavar (sorafenib) for the treatment of advanced hepatocellular carcinoma (HCC) – a form of...

Kimberly-Clark appoints new VP for UK and Ireland

Kimberly-Clark, a leading manufacturer of hygiene products for healthcare and other markets, has appointed Kim Underhill as Vice President, UK and Ireland. Kim...

Haymarket relaunches primary care web resource

Haymarket has relaunched its leading primary care website, Healthcare Republic, with a new design and search function. The site is designed to provide users...

Karolinska establishes new company

Karolinska Development has formed a new company, Pergamum AB, to commercialise its development projects in dermatology and wound healing. Karolinska Development has transferred all...

STAR opens Maidenhead office

Healthcare and medical sales recruitment consultancy STAR has officially opened its third premises: a new office in Maidenhead. STAR, with the backing of Dragon’s...

Cardiac therapy with ICD saves lives

The combination of cardiac therapy and implantable device treatment can save lives and reduce the costs of healthcare for patients with cardiovascular diseases (CVD),...

Sectra launches online social newsroom

Swedish medtech and IT company Sectra has launched an online social newsroom, www.newsroom.sectra.com. The virtual newsroom presents articles, trend coverage and information within...

Promising results with anti-Alzheimer’s agents

A series of iron-binding agents has shown promising potential in the prevention of Alzheimer’s disease. The new compounds can bind to excess iron in...

SEP to market OAB therapy in UK

Regurin XL (trospium chloride), a once-daily capsule to treat patients with overactive bladder (OAB), has been launched in the UK. Rottapharm Madaus has granted...

New leader for Nexxus

Nexxus, the networking organisation for central Scotland's life science industry and researchers, has appointed a new Director. Graeme Boyle joins Nexxus following 25...

Latest articles

Man standing at flipboard with graphs and charts on it to show Fewer than half of US clinical trials comply with law on reporting results

Fewer than half of US clinical trials comply with law on reporting results

Research into reporting of US clinical trial results finds that less than half (41%) are reported promptly onto the US trial registry, and one...
Image of blood bag to show study confirms benefits of blood anticoagulants for heart failure patients

Study confirms benefits of blood anticoagulants for heart failure patients

British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
graphic of handshake with couple signing a contract in background to depict Bayer and Exscientia collaborate on AI in cardiovascular and oncology drug discovery

Lynparza regulatory submission granted Priority Review in US

AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...

Popular articles

Image of doctor in a circle with lots of medical icons filtering out in a circular pattern to show mapping the intricate oncology landscape

Mapping the intricate oncology landscape

Simon Grime, of Wilmington Healthcare, explains how data and intelligence tools help pharma deliver tailored engagement programmes to diverse stakeholders in an intricate oncology...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
graphic of handshake with couple signing a contract in background to depict Bayer and Exscientia collaborate on AI in cardiovascular and oncology drug discovery

Lynparza regulatory submission granted Priority Review in US

AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...
Image of blood bag to show study confirms benefits of blood anticoagulants for heart failure patients

Study confirms benefits of blood anticoagulants for heart failure patients

British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
moving up the career ladder: Making a career move in pharma

Making a career move in pharma

If you feel that you have gone as far as you can in your current role, it could be time to make a career...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription